Jesse T Davidson

4PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Haematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 14, 2020
cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity.

Stephen T Ferris, Vivek Durai, Renee Wu

|Aug 14, 2019
Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.

Vivek Durai, Prachi Bagadia, Jeffrey M Granja

|Dec 27, 2018
Staging laparoscopy among three subtypes of extra-hepatic biliary malignancy: a 15-year experience from 10 institutions.

Jesse T Davidson, Linda X Jin, Bradley Krasnick

|Nov 10, 2018
WDFY4 is required for cross-presentation in response to viral and tumor antigens.

Derek J Theisen, Jesse T Davidson, Carlos G Briseño

Pageof 1